Nath Bio Genes India Limited
Fundamental Score
Nath Bio Genes India Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of NATHBIOGEN across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 7.25 vs Industry: 21.07)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (126.13%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (36.22%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Conservative Debt Levels (D/E: 0.23)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Risk Factors
4 factors identified
Below-Average Return on Equity (6.23%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.96%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Limited Institutional Interest (FII+DII: 1.08%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Nath Bio Genes India Limited
About NATHBIOGEN
Business Overview
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
NATHBIOGEN Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Nath Bio Genes India Limited (NATHBIOGEN)?
As of 02 Feb 2026, 10:15 am IST, Nath Bio Genes India Limited (NATHBIOGEN) is currently trading at ₹149.39. The stock has a market capitalization of ₹299.59 (Cr).
Is NATHBIOGEN share price Overvalued or Undervalued?
NATHBIOGEN is currently trading at a P/E ratio of 7.25x, compared to the industry average of 21.07x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Nath Bio Genes India Limited share price?
Key factors influencing NATHBIOGEN's price include its quarterly earnings growth (Sales Growth: 36.22%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Nath Bio Genes India Limited a good stock for long-term investment?
Nath Bio Genes India Limited shows a 5-year Profit Growth of N/A% and an ROE of 6.23%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.23 before investing.
How does Nath Bio Genes India Limited compare with its industry peers?
Nath Bio Genes India Limited competes with major peers in the Other Agricultural Products. Investors should compare NATHBIOGEN's P/E of 7.25x and ROE of 6.23% against the industry averages to determine its competitive standing.
What is the P/E ratio of NATHBIOGEN and what does it mean?
NATHBIOGEN has a P/E ratio of 7.25x compared to the industry average of 21.07x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹7 for every ₹1 of annual earnings.
How is NATHBIOGEN performing according to Bull Run's analysis?
NATHBIOGEN has a Bull Run fundamental score of 27.2/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does NATHBIOGEN belong to?
NATHBIOGEN operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Nath Bio Genes India Limited.
What is Return on Equity (ROE) and why is it important for NATHBIOGEN?
NATHBIOGEN has an ROE of 6.23%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Nath Bio Genes India Limited generates profits from shareholders' equity.
How is NATHBIOGEN's debt-to-equity ratio and what does it indicate?
NATHBIOGEN has a debt-to-equity ratio of 0.23, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is NATHBIOGEN's dividend yield and is it a good dividend stock?
NATHBIOGEN offers a dividend yield of 1.27%, which means you receive ₹1.27 annual dividend for every ₹100 invested.
How has NATHBIOGEN grown over the past 5 years?
NATHBIOGEN has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in NATHBIOGEN and why does it matter?
Promoters hold 45.59% of NATHBIOGEN shares, with 13.78% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is NATHBIOGEN's market capitalization category?
NATHBIOGEN has a market capitalization of ₹300 crores, placing it in the Small-cap category.
How volatile is NATHBIOGEN stock?
NATHBIOGEN has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for NATHBIOGEN?
NATHBIOGEN has a 52-week high of ₹N/A and low of ₹N/A.
What is NATHBIOGEN's operating profit margin trend?
NATHBIOGEN has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is NATHBIOGEN's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 36.22% and YoY Profit Growth of 126.13%.
What is the institutional holding pattern in NATHBIOGEN?
NATHBIOGEN has FII holding of 0.32% and DII holding of 0.76%. Significant institutional holding often suggests professional confidence in the stock.